Alexion to highlight advances across its rare neurology portfolio at AANEM and MGFA 2025
Alexion, AstraZeneca Rare Disease, will deliver 18 presentations, including four oral presentations, from its leading rare neurology portfolio at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)… read more.
